COMMUNIQUÉS West-GlobeNewswire

Syncromune Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium
16/06/2026
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, June 16, 2026 (GLOBE NEWSWIRE) -- Syncromune, Inc., a privately held clinical-stage biopharmaceutical company developing SYNC-T™, an investigational in situ multi-target [...]
CDT Equity Announces Debt Update and New Loan Facility
16/06/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, June 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has re-structured its debt, agreeing to pay off all [...]
First Steps Developmental Services Expands School Partnership Program to Support Massachusetts Students and Educators
16/06/2026
Behavior Technician support, BCBA consultation, and school-based behavioral services help Massachusetts schools maintain continuity of support for students during staffing shortages, extended absences, and other [...]
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
16/06/2026
Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by mid-July 2026, with [...]
Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations
16/06/2026
The agreement with Lovell Government Services creates opportunities to sell the LIBERTY® System at more than 2,000 government facilities, including those administered by the U.S. Department of Veterans Affairs, the [...]
FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers
16/06/2026
Company continues to advance CYWC628 manufacturing with second GMP drug product run released for shipment to Australia and a third run nearing completion HOUSTON, June 16, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. ( [...]
Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program
16/06/2026
Four of Six Patients Participating in the Compassionate Use Program Were Classified as ‘Improved’ or ‘Significantly Improved’ from Baseline Assessment Across Key Clinical Endpoints All Six Patients Are Younger than 10 [...]
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
16/06/2026
Exclusivity Extended into December 2042 KANSAS CITY, Kan., June 16, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug [...]
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure
16/06/2026
NewGen to repurchase all outstanding convertible notes and warrants previously held by a significant investor in move to strengthen its capital structure Settlement to eliminate potential dilution from convertible notes [...]
Klow Peptide Stack Introduced by Koi Peptides for Laboratory Research in 2026
16/06/2026
Sheridan, WY, June 16, 2026 (GLOBE NEWSWIRE) -- Koi Peptides (Koi Research Labs LLC) has introduced Klow Peptide Stack as a research-use-only multi-peptide blend for laboratory research in 2026. The product contains GHK [...]
King Faisal Specialist Hospital Presents Robotic Surgery as a Model for Innovation-Driven Specialized Care at HLTH Europe 2026
16/06/2026
AMSTERDAM, June 16, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) is highlighting its leadership in robotic surgery during its participation at HLTH Europe 2026, taking place from [...]
GHK-Cu For Sale At Koi Peptides for Laboratory Use in 2026
16/06/2026
SHERIDAN, WY, June 16, 2026 (GLOBE NEWSWIRE) -- Koi Peptides has launched GHK-Cu, the copper tripeptide-1 complex that forms when copper(II) binds glycyl-L-histidyl-L-lysine (a tripeptide), as a research-use-only [...]
Une famille soutient la recherche sur les cancers rares par l’intermédiaire de la Fondation du CUSM
16/06/2026
MONTRÉAL, 16 juin 2026 (GLOBE NEWSWIRE) -- La générosité d’une famille permet de réaliser une percée majeure dans la recherche sur les cancers rares au CUSM. Dans le cadre du Projet SDR de la Fondation du CUSM, Jim [...]
Le King Faisal Specialist Hospital présente la chirurgie robotique comme modèle de soins spécialisés axés sur l’innovation lors du congrès HLTH Europe 2026
16/06/2026
AMSTERDAM, 16 juin 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) met en avant son leadership en chirurgie robotique à l’occasion de sa participation au congrès HLTH Europe 2026 [...]
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
16/06/2026
Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studies New microdose formats extend Optimi's psilocybin range, which [...]
Breckenridge Distillery Celebrates America's 250th Anniversary with the Launch of Patriotic Reserve Bourbon Whiskey
16/06/2026
A limited-release American-crafted whiskey honoring the nation’s milestone anniversary, the spirit of Independence Day, and the veterans and active-duty service members who help protect it BRECKENRIDGE, Colo., June 16, [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
16/06/2026
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 16 June 2026 at 16.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
16/06/2026
Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research MINNEAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused [...]
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
16/06/2026
The regulatory approved CELZ-Biodefense platform is designed to scale to at least 1,000 veterans through AI-enabled mobile-app data collection and field-capable logistics Proprietary CELZ-Biodefense Toxic Exposure Atlas [...]

Pages